This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Drugstore.com Most Likely Amazon M&A Target: Poll

Stocks in this article: AMZN DSCM NILE OPEN NFLX

NEW YORK ( TheStreet) -- Amazon's (AMZN - Get Report) next M&A target will be Drugstore.com (DSCm), according to TheStreet readers.

Following Amazon's $545 million purchase earlier this week of Quidsi, which operates Diapers.com and Soap.com, we asked readers what other company is most likely on Amazon's radar for an acquisition. According to the poll, 37.6% say Drugstore.com is the most likely buyout.

The online retailer of health, beauty, vision and pharmacy products would be a natural fit in Amazon's own growth of its pharmacy and vitamin business.

Last week Drugstore.com reported third-quarter earnings of $2.4 million, or 2 cents a share, compared with a loss of $1.6 million, or 2 cents, in the year prior. Sales surged 23% to $108.8 million from $88.6 million. Analysts forecast earnings of 3 cents a share on revenue of $108.9 million.

Netflix (NFLX - Get Report) is the second most likely Amazon target, according to 29.8% of voters. The Internet movie rental company has been rumored to be a potential acquisition, but many analysts have predicted that the time has passed for any such deal.

Regardless, investors are still holding out hope as Netflix continues to report break-neck growth. Netflix could become more attractive to Amazon as it moves from a DVD-by-mail company into a streaming company. Amazon has been losing out to Apple's (AAPL) iTunes and other competitors in the streaming movies business and the acquisition of a firm with Netflix's caliber could push it ahead of the pack.

Blue Nile (NILE - Get Report) got 20.3% of the vote, while just 12.3% of voters said Amazon will consider OpenTable (OPEN).

--Written by Jeanine Poggi in New York.



>To contact the writer of this article, click here: Jeanine Poggi.

>To follow the writer on Twitter, go to http://twitter.com/jpoggi.

>To submit a news tip, send an email to: tips@thestreet.com.

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs